Sara Grant, Lappin Julia, Dobbins Timothy, Dunlop Adrian J, Degenhardt Louisa
Northern Clinical School, Sydney Medical School, University of Sydney, Kolling Building Level 7, Royal North Shore Hospital, Reserve Road, St Leonards, NSW 2065, Australia; InforMH, Health System Information and Performance Reporting Branch, NSW Ministry of Health, PO Box 169, North Ryde, NSW 1670, Australia.
National Drug and Alcohol Research Centre, University of NSW, Sydney, NSW 2052, Australia; Department of Psychiatry, University of NSW, Sydney NSW 2052, Australia.
Drug Alcohol Depend. 2017 Nov 1;180:171-177. doi: 10.1016/j.drugalcdep.2017.08.009. Epub 2017 Sep 6.
To describe health service contact in the two years prior to a first hospital admission with amphetamine-related psychosis, and to identify possible opportunities for early intervention.
Routine health data collections were used to identify 6130 persons aged 16-65 who had a first hospital admission with amphetamine-related psychosis in New South Wales (NSW), Australia, between 2005 and 2016. Health service contacts in the two years prior to first admission were identified, using public hospital, emergency department and community mental health data. Prior care was compared to 41,444 people with first psychosis admissions without amphetamine diagnoses.
Two thirds of people with amphetamine-related psychosis had health service contact in the two years prior to their first psychosis admission. Of these, 45% had ED contacts and 30% had prior general hospital admissions. The likelihood of contact escalated throughout the two years prior to admission. Prior substance-related conditions, infectious diseases, injuries and accidents were common. Compared to other first psychosis admissions, people with amphetamine-related psychoses were less likely to have prior specialised mental health care (OR 0.84, 95% CI 0.78, 0.89) and more likely to have prior general health care (OR 1.40, 95% CI 1.29, 1.51).
Emergency departments and units treating people with infectious diseases or injuries should consider strategies to detect amphetamine and other substance use. Early detection and referral to specialist mental health or drug and alcohol care may prevent some amphetamine-related psychoses.
描述首次因苯丙胺类精神病住院治疗前两年内的医疗服务接触情况,并确定早期干预的可能机会。
利用常规健康数据收集,识别出2005年至2016年间在澳大利亚新南威尔士州(NSW)首次因苯丙胺类精神病住院的6130名16至65岁的患者。使用公立医院、急诊科和社区心理健康数据,确定首次入院前两年内的医疗服务接触情况。将之前的护理情况与41444名首次因精神病入院但无苯丙胺诊断的患者进行比较。
三分之二的苯丙胺类精神病患者在首次精神病入院前两年内有医疗服务接触。其中,45%有急诊科接触史,30%有之前的综合医院住院史。在入院前的两年中,接触的可能性逐渐增加。之前与物质相关的疾病、传染病、损伤和事故很常见。与其他首次精神病入院患者相比,苯丙胺类精神病患者之前接受专科心理健康护理的可能性较小(比值比0.84,95%可信区间0.78,0.89),而之前接受综合医疗护理的可能性较大(比值比1.40,95%可信区间1.29,1.51)。
急诊科以及治疗传染病或损伤患者的科室应考虑采取策略来检测苯丙胺及其他物质的使用情况。早期发现并转诊至专科心理健康或药物及酒精护理机构可能预防一些与苯丙胺相关的精神病。